Non‑Alcoholic Fatty Liver Disease (NAFLD) - Then vs. Now
In 1990, roughly 8.2% of the global population had NAFLD (about 391 million people).
By Irina Stoica · · 1 min read
Global Trends
In 1990, roughly 8.2% of the global population had NAFLD (about 391 million people).
By 2017, prevalence rose to 10.9%, affecting 882 million people globally - more than double the case count over three decades
Western Trends
In the United States, NAFLD prevalence increased from approximately 20% in the late 1980s–early 1990s to around 38% today - a nearly 50% rise in just 30 years .
Broader Global Perspective
More recent reports estimate roughly 24–30% prevalence worldwide, with parallel rises observed in Asia .
Working-age populations saw a substantial 112% increase in NAFLD cases from 1990 to 2019 - from ~14,478 to ~19,838 per 100,000 population
🔬 What This Means for You
Fat accumulation in the liver - traditionally rare - has now become a leading metabolic health concern globally.
The rise reflects escalating obesity, insulin resistance, and consumption of refined sugars (including fructose) - dietary factors closely tied to the topic of our sugar article.
Addressing sugar intake, blood sugar balance, and stress is not just about waistline - it’s essential for long-term liver and metabolic resilience.
This article is general education, not medical advice. Please speak with a qualified healthcare professional about your own circumstances. Health Disclaimer
Enjoyed this article?
Join the newsletter to receive new Journal pieces.
Keep reading
GLP‑1 Medications: From Diabetes Breakthrough to Risky DIY Trend
GLP‑1 drugs transformed diabetes care and weight management under medical supervision. But unsupervised use, black‑market sourcing, and dosage experimentation pose real risks.
